[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368322-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368322-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","single-cell-sequencing-combined-with-urinary-multi-omics-analysis-reveals-that-the-non-invasive-biomarker-prdx5-regulates-bladder-cancer-progression-through-ferroptosis-signaling","Single-cell sequencing combined with urinary multi-omics analysis reveals that the non-invasive biomarker PRDX5 regulates bladder cancer progression through ferroptosis signaling","","Study objective: define PRDX5 expression patterns in bladder cancer and clarify how PRDX5 influences tumor progression by modulating reactive oxygen species (ROS) levels and activating ferroptosis pathways. Methods integrate urine proteomics and TCGA transcriptomics to identify PRDX5-related differential genes, then use single-cell RNA sequencing to map PRDX5 across tumor microenvironment cell types. Functional assays assess proliferation, migration and invasion in vitro, with ferroptosis signaling evaluated in vivo. Results show PRDX5 upregulation, enrichment in bladder epithelial cells, and enhanced malignancy-associated phenotypes when PRDX5 is overexpressed, reversed by knockout. Conclusion: elevated PRDX5 drives progression via ROS/ferroptosis regulation and supports PRDX5 as a potential therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/single-cell-sequencing-combined-with-urinary-multi-omics-analysis-reveals-that-the-non-invasive-biomarker-prdx5-regulates-bladder-cancer-progression-through-ferroptosis-signaling/368322/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/single-cell-sequencing-combined-with-urinary-multi-omics-analysis-reveals-that-the-non-invasive-biomarker-prdx5-regulates-bladder-cancer-progression-through-ferroptosis-signaling/368322.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the study?","Question",{"text":63,"@type":64},"The study aims to characterize PRDX5 expression in bladder cancer and determine how PRDX5 regulates bladder cancer progression through ROS modulation and ferroptosis pathway activation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were PRDX5-related genes and cell distributions analyzed?",{"text":68,"@type":64},"The study used urine proteomics data and TCGA transcriptomic information to identify differentially expressed genes, and single-cell RNA sequencing to assess PRDX5 distribution across cell types in the tumor microenvironment.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key experimental findings regarding PRDX5 function?",{"text":72,"@type":64},"PRDX5 was significantly upregulated in bladder cancer tissues and enriched in bladder epithelial cells. PRDX5 overexpression promoted proliferation, migration, and invasion, while PRDX5 knockout produced opposing effects, accompanied by changes in ROS levels and ferroptosis signaling in vitro and in vivo.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368322,1790800889,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Wan etal. BMC Cancer (2025) 25:533 [https://doi.org/10.1186/s12885-025-13881-y](https://doi.org/10.1186/s12885-025-13881-y)  \nBMC Cancer  \n RESEARCH Open Access  \nSingle-cell sequencing combined with urinary multi-omics analysis reveals that the non-invasive biomarker PRDX5 regulates bladder cancer progression through ferroptosis signaling  \nShun Wan1,2†, Kun‑peng Li 1,2†, Si‑yu Chen 1,2†, Chen‑yang Wang1,2, Kun Cheng1,2, Jian‑wei Yang1, Li‑yun Ding3, Tuan‑jie Che4, Shan‑hui Liu 1,2* and Li Yang1,2*  \nAbstract  \nObjective This study aimed to elucidate the expression profile and biological implications of peroxidase 5 (PRDX5) in bladder cancer (BC), specifically investigating its influence on BC progression through modulation of reactive oxy‑ gen species (ROS) levels and activation offerroptosis pathways.  \nMethods We employed urine proteomics data and transcriptomic information from the Cancer Genome Atlas (TCGA) to identify differentially expressed genes in BC tissues, focusing on PRDX5 . Using single‑cell RNA sequencing (scRNA‑seq), we assessed PRDX5 distribution across various cell types in the tumor microenvironment. We conducted in vitro experiments to analyze the impact of PRDX5 on BC cell proliferation, migration, and invasion, while exploring its mechanisms of modulating ROS levels and ferroptosis. In vivo experiments were performed to observe PRDX5’s influence on ferroptosis signaling in tissue contexts.  \nResults We found significant upregulation of PRDX5 in BC tissues, with scRNA‑seq revealing its enrichment in bladder epithelial cells, correlating with disease advancement and established BC markers. In vitro analyses showed that overex‑ pressed PRDX5 enhanced proliferation, migration, and invasion of BC cells, while PRDX5 knockout produced opposing effects. Additionally, PRDX5 modulated ROS levels and impacted ferroptosis pathways. In vivo experiments confirmed that PRDX5 knockout inhibited tumor growth and activated ferroptosis signaling pathways in tissues.  \nConclusion Our study highlights the elevated expression of PRDX5 in BC and its role in promoting tumor progres‑ sion through regulation of ROS levels and ferroptosis. PRDX5 may serve as a promising target for BC treatment, sup‑ porting further exploration of its potential in clinical applications.  \nKeywords Bladder cancer, PRDX5, Ferroptosis, Multi‑omics, Urine, Progression, Single cell  \n†Shun Wan, Kun‑peng Li and Si‑yu Chen contributed equally to this work.  \n*Correspondence: Shan‑hui Liu [1106074594@qq.com](1106074594@qq.com)[ ](1106074594@qq.com)Li Yang[ery_yangli@lzu.edu.cn](ery_yangli@lzu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution‑NonCommercial‑NoDerivatives 4.0 International License, which permits any non‑commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by‑nc‑nd/4.0/.  \nWan etal. BMC Cancer (2025) 25:533  \nIntroduction  \nBladder cancer (BC) is one of the most common malignancies affecting the urinary system [1, 2]. Global statistics indicate that approximately 540,000 new cases of BC are diagn","cbCaienkEeWS9zin","https://ap.wps.com/l/cbCaienkEeWS9zin","pdf",12445140,18,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Background on bladder cancer and clinical challenges\n## Redox biology, ROS, and ferroptosis as mechanistic context","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"The study aims to characterize PRDX5 expression in bladder cancer and determine how PRDX5 regulates bladder cancer progression through ROS modulation and ferroptosis pathway activation.\"},{\"question\":\"How were PRDX5-related genes and cell distributions analyzed?\",\"answer\":\"The study used urine proteomics data and TCGA transcriptomic information to identify differentially expressed genes, and single-cell RNA sequencing to assess PRDX5 distribution across cell types in the tumor microenvironment.\"},{\"question\":\"What were the key experimental findings regarding PRDX5 function?\",\"answer\":\"PRDX5 was significantly upregulated in bladder cancer tissues and enriched in bladder epithelial cells. PRDX5 overexpression promoted proliferation, migration, and invasion, while PRDX5 knockout produced opposing effects, accompanied by changes in ROS levels and ferroptosis signaling in vitro and in vivo.\"}]","Single-cell sequencing combined with urinary multi-omics analysis reveals that the non-invasive biomarker PRDX5 regulates bladder cancer progression through ferroptosis signaling | PDF",1790176317,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f65b08ad69011847955bf2eb685326de.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22f1e412ca527c08b0c8d48f34e36331.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6673cdee967ca8b3ab79567b2f4868fd.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f36200b686ff4d31930bdeb6da93c22.webp",980,1301]